SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-045170
Filing Date
2023-09-26
Accepted
2023-09-26 07:05:21
Documents
14
Period of Report
2023-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20011263_8k.htm   iXBRL 8-K 25575
2 EXHIBIT 99.1 ef20011263_ex99-1.htm EX-99.1 22914
6 image0.jpg GRAPHIC 7709
  Complete submission text file 0001140361-23-045170.txt   200954

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20230926.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20230926_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20230926_pre.xml EX-101.PRE 16050
8 EXTRACTED XBRL INSTANCE DOCUMENT ef20011263_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 231277154
SIC: 2834 Pharmaceutical Preparations